-
Product Insights
NewLikelihood of Approval Analysis for Liposarcoma
Overview How likely is it that the drugs in Liposarcoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Liposarcoma Overview Liposarcoma is a rare tumor derived from fat tissue that occurs...
-
Product Insights
NewLikelihood of Approval Analysis for Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD))
Overview How likely is it that the drugs in Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) Overview Adrenoleukodystrophy is a disorder that...
-
Product Insights
NewLikelihood of Approval Analysis for Hyperlipidemia
Overview How likely is it that the drugs in Hyperlipidemia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hyperlipidemia Overview Hyperlipidemia is a medical condition characterized by elevated levels of lipids...
-
Product Insights
NewLikelihood of Approval Analysis for Cardiovascular Inflammation
Overview How likely is it that the drugs in Cardiovascular Inflammation will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cardiovascular Inflammation Overview Cardiovascular inflammation refers to inflammation that occurs in the...
-
Product Insights
NewLikelihood of Approval Analysis for Lipid Disorders
Overview How likely is it that the drugs in Lipid Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lipid Disorders Overview Abnormal levels of triglycerides and LDL in the blood....
-
Product Insights
NewLikelihood of Approval Analysis for Obesity
Overview How likely is it that the drugs in Obesity will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Obesity Overview Obesity, a complex medical condition characterized by excessive body fat accumulation,...
-
Product Insights
NewLikelihood of Approval Analysis for Non-Rhabdomyosarcoma
Overview How likely is it that the drugs in Non-Rhabdomyosarcoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Non-Rhabdomyosarcoma Overview Non-rhabdomyosarcoma refers to a group of cancers that are distinct from...
-
Product Insights
NewLikelihood of Approval Analysis for Lipid Storage Disorders (Lipidoses)
Overview How likely is it that the drugs in Lipid Storage Disorders (Lipidoses) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lipid Storage Disorders (Lipidoses) Overview Lipid storage disorders, or lipidoses,...
-
Product Insights
NewLikelihood of Approval Analysis for Mesenchymal Tumor
Overview How likely is it that the drugs in Mesenchymal Tumor will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mesenchymal Tumor Overview Mesenchymal tumors are tumors developing from mesenchymal tissues. These...
-
Product Insights
NewLikelihood of Approval Analysis for Hypertriglyceridemia
Overview How likely is it that the drugs in Hypertriglyceridemia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hypertriglyceridemia Overview Hypertriglyceridemia is a condition in which the blood contains high levels...